These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 17967510

  • 1. The impact of tumor expression of erythropoietin receptors and erythropoietin on clinical outcome of esophageal cancer patients treated with chemoradiation.
    Rades D, Golke H, Schild SE, Kilic E.
    Int J Radiat Oncol Biol Phys; 2008 May 01; 71(1):152-9. PubMed ID: 17967510
    [Abstract] [Full Text] [Related]

  • 2. Radio(chemo)therapy plus resection versus radio(chemo)therapy alone for the treatment of stage III esophageal cancer.
    Rades D, Schulte R, Yekebas EF, Homann N, Schild SE, Dunst J.
    Strahlenther Onkol; 2007 Jan 01; 183(1):10-6. PubMed ID: 17225940
    [Abstract] [Full Text] [Related]

  • 3. Epoetin alfa improves survival after chemoradiation for stage III esophageal cancer: final results of a prospective observational study.
    Rades D, Tribius S, Yekebas EF, Bahrehmand R, Wildfang I, Kilic E, Muellerleile U, Gross E, Schild SE, Alberti W.
    Int J Radiat Oncol Biol Phys; 2006 Jun 01; 65(2):459-65. PubMed ID: 16584851
    [Abstract] [Full Text] [Related]

  • 4. [Expression of erythropoietin receptor in esophageal carcinoma and its correlation to microvessel density].
    Li M, Lu Y, Chen XQ.
    Ai Zheng; 2008 Jan 01; 27(1):52-7. PubMed ID: 18184464
    [Abstract] [Full Text] [Related]

  • 5. Biologic factors associated with tumor oxygenation are prognostic in patients with stage III esophageal cancer: long-term results.
    Rades D, Bajrovic A, Schild SE, Thorns C, Kilic E.
    Anticancer Res; 2014 Aug 01; 34(8):4351-5. PubMed ID: 25075070
    [Abstract] [Full Text] [Related]

  • 6. Prognostic impact of erythropoietin expression and erythropoietin receptor expression on locoregional control and survival of patients irradiated for stage II/III non-small-cell lung cancer.
    Rades D, Setter C, Dahl O, Schild SE, Noack F.
    Int J Radiat Oncol Biol Phys; 2011 Jun 01; 80(2):499-505. PubMed ID: 20646855
    [Abstract] [Full Text] [Related]

  • 7. Radiotherapy with or without erythropoietin for anemic patients with head and neck cancer: a randomized trial of the Radiation Therapy Oncology Group (RTOG 99-03).
    Machtay M, Pajak TF, Suntharalingam M, Shenouda G, Hershock D, Stripp DC, Cmelak AJ, Schulsinger A, Fu KK, Radiation Therapy Oncology Group.
    Int J Radiat Oncol Biol Phys; 2007 Nov 15; 69(4):1008-17. PubMed ID: 17716826
    [Abstract] [Full Text] [Related]

  • 8. Erythropoietin and erythropoietin receptor coexpression is associated with poor survival in stage I non-small cell lung cancer.
    Saintigny P, Besse B, Callard P, Vergnaud AC, Czernichow S, Colombat M, Girard P, Validire P, Breau JL, Bernaudin JF, Soria JC.
    Clin Cancer Res; 2007 Aug 15; 13(16):4825-31. PubMed ID: 17699861
    [Abstract] [Full Text] [Related]

  • 9. Epoetin-alpha during radiotherapy for stage III esophageal carcinoma.
    Rades D, Schild SE, Yekebas EF, Job H, Schwarz R, Rudat V.
    Cancer; 2005 Jun 01; 103(11):2274-9. PubMed ID: 15852356
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of prognostic factors and two radiation techniques in patients treated with surgery followed by radio(chemo)therapy or definitive radio(chemo)therapy for locally advanced head-and-neck cancer.
    Rades D, Stoehr M, Meyners T, Bohlen G, Nadrowitz R, Dunst J, Schild SE, Wroblewski J, Albers D, Schmidt R, Alberti W, Tribius S.
    Strahlenther Onkol; 2008 Apr 01; 184(4):198-205. PubMed ID: 18398584
    [Abstract] [Full Text] [Related]

  • 11. Prognostic significance of erythropoietin expression in human endometrial carcinoma.
    Acs G, Xu X, Chu C, Acs P, Verma A.
    Cancer; 2004 Jun 01; 100(11):2376-86. PubMed ID: 15160341
    [Abstract] [Full Text] [Related]

  • 12. Low expression of Bax predicts poor prognosis in patients with locally advanced esophageal cancer treated with definitive chemoradiotherapy.
    Kang SY, Han JH, Lee KJ, Choi JH, Park JI, Kim HI, Lee HW, Jang JH, Park JS, Kim HC, Kang S, Oh YT, Chun M, Kim JH, Sheen SS, Lim HY.
    Clin Cancer Res; 2007 Jul 15; 13(14):4146-53. PubMed ID: 17634542
    [Abstract] [Full Text] [Related]

  • 13. [Influence of tumor necrosis factor-alpha and interferon-gamma on erythropoietin production and erythropoiesis in cancer patients with anemia].
    Wang W, Zhang MH, Yu Y, Xu CG.
    Zhonghua Xue Ye Xue Za Zhi; 2007 Oct 15; 28(10):681-4. PubMed ID: 18399174
    [Abstract] [Full Text] [Related]

  • 14. Do erythropoietin receptors on cancer cells explain unexpected clinical findings?
    Henke M, Mattern D, Pepe M, Bézay C, Weissenberger C, Werner M, Pajonk F.
    J Clin Oncol; 2006 Oct 10; 24(29):4708-13. PubMed ID: 17028293
    [Abstract] [Full Text] [Related]

  • 15. Improved local control by surgery and paclitaxel-based chemoradiation for esophageal squamous cell carcinoma: results of a retrospective non-randomized study.
    Hsu FM, Lin CC, Lee JM, Chang YL, Hsu CH, Tsai YC, Lee YC, Cheng JC.
    J Surg Oncol; 2008 Jul 01; 98(1):34-41. PubMed ID: 18449912
    [Abstract] [Full Text] [Related]

  • 16. Prognostic significance of blood transfusions in patients with esophageal cancer treated with combined chemoradiotherapy.
    Kader AS, Lim JT, Berthelet E, Petersen R, Ludgate D, Truong PT.
    Am J Clin Oncol; 2007 Oct 01; 30(5):492-7. PubMed ID: 17921709
    [Abstract] [Full Text] [Related]

  • 17. Prognostic factors affecting locally recurrent rectal cancer and clinical significance of hemoglobin.
    Rades D, Kuhn H, Schultze J, Homann N, Brandenburg B, Schulte R, Krull A, Schild SE, Dunst J.
    Int J Radiat Oncol Biol Phys; 2008 Mar 15; 70(4):1087-93. PubMed ID: 17892921
    [Abstract] [Full Text] [Related]

  • 18. Squamous cell carcinoma of the oral tongue: a 25-year, single institution experience.
    Mosleh-Shirazi MS, Mohammadianpanah M, Mosleh-Shirazi MA.
    J Laryngol Otol; 2009 Jan 15; 123(1):114-20. PubMed ID: 18588737
    [Abstract] [Full Text] [Related]

  • 19. Erythropoietin and the erythropoietin receptor are expressed by papillary thyroid carcinoma from children and adolescents. Expression of erythropoietin receptor might be a favorable prognostic indicator.
    Eccles TG, Patel A, Verma A, Nicholson D, Lukes Y, Tuttle RM, Francis GL.
    Ann Clin Lab Sci; 2003 Jan 15; 33(4):411-22. PubMed ID: 14584755
    [Abstract] [Full Text] [Related]

  • 20. Expression of erythropoietin receptor and in vitro functional effects of epoetins in B-cell malignancies.
    Kokhaei P, Abdalla AO, Hansson L, Mikaelsson E, Kubbies M, Haselbeck A, Jernberg-Wiklund H, Mellstedt H, Osterborg A.
    Clin Cancer Res; 2007 Jun 15; 13(12):3536-44. PubMed ID: 17575216
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.